Publication:
Discontinued drugs in 2006: Pulmonary-allergy, dermatological, gastrointestinal and arthritis drugs

dc.contributor.authorsOzdemir C., Akdis C.A.
dc.date.accessioned2022-03-15T01:55:46Z
dc.date.accessioned2026-01-11T08:06:31Z
dc.date.available2022-03-15T01:55:46Z
dc.date.issued2007
dc.description.abstractThis perspective is the second in a series discussing drugs dropped from development in 2006, with a focus on pulmonary-allergy, dermatological, gastrointestinal and arthritis drugs. A survey of discontinued drugs from 2006 is provided, based on data from the Pharmaprojects database, along with an analysis of biology, mechanisms of action and economic considerations in developing new drugs. © 2007 Informa UK Ltd.
dc.identifier.doi10.1517/13543784.16.9.1327
dc.identifier.issn13543784
dc.identifier.pubmed17714020
dc.identifier.urihttps://hdl.handle.net/11424/246780
dc.language.isoeng
dc.relation.ispartofExpert Opinion on Investigational Drugs
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectArthritis
dc.subjectAsthma
dc.subjectAtopic eczema
dc.subjectDiscontinued drugs
dc.subjectNew drugs
dc.subjectPsoriasis
dc.titleDiscontinued drugs in 2006: Pulmonary-allergy, dermatological, gastrointestinal and arthritis drugs
dc.typearticle
dspace.entity.typePublication
oaire.citation.endPage1344
oaire.citation.issue9
oaire.citation.startPage1327
oaire.citation.titleExpert Opinion on Investigational Drugs
oaire.citation.volume16

Files